Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Chinese Patent Office
Teva
Johnson and Johnson
Queensland Health
McKinsey
Colorcon
Boehringer Ingelheim
AstraZeneca
QuintilesIMS

Generated: January 17, 2018

DrugPatentWatch Database Preview

Meclizine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for meclizine hydrochloride and what is the scope of meclizine hydrochloride patent protection?

Meclizine hydrochloride
is the generic ingredient in two branded drugs marketed by Casper Pharma Llc, Ivax Sub Teva Pharms, Nexgen Pharma Inc, Pliva, Abc Holding, Amneal Pharms, Anabolic, Ani Pharms Inc, Bundy, Epic Pharma Llc, Jubilant Cadista, Kv Pharm, Mylan Pharms Inc, Par Pharm, Rising Pharms Inc, Sandoz, Superpharm, UDL, Vangard, and Watson Labs, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for meclizine hydrochloride. Forty-one suppliers are listed for this compound.
Pharmacology for meclizine hydrochloride
Drug ClassAntiemetic
Physiological EffectEmesis Suppression
Medical Subject Heading (MeSH) Categories for meclizine hydrochloride

US Patents and Regulatory Information for meclizine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 084657-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Kv Pharm MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 085524-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 084092-003 May 22, 1989 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 085740-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 089674-001 Mar 31, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Casper Pharma Llc ANTIVERT meclizine hydrochloride TABLET, CHEWABLE;ORAL 010721-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 084975-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anabolic MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 085891-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abc Holding MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 085252-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 084843-002 May 22, 1989 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Farmers Insurance
Argus Health
McKinsey
Chubb
Moodys
McKesson
Federal Trade Commission
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot